EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

COVID‐19 Hospitalizations, Vaccine Uptake, Vaccination Guidelines, and Vaccine Availability in Six Middle‐Income Countries and Areas in Europe, May 2022–April 2024

Erin Rachel Whitehouse iD, Paul Elish iD, Elona Kureta, Dragan Kochinski, Dragana Plavsa, Giorgi Chakhunashvili, Besfort Kryeziu iD, Sayragul Abdyldaeva, Miguel Angel Sanchez Ruiz, Sandra Cohuet, James Humphreys iD, Kujtim Mersini und 11 weitere

Influenza and Other Respiratory Viruses · 2025

DOI: 10.1111/irv.70126 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Influenza and Other Respiratory Viruses, 2025. Verfasst von Erin Rachel Whitehouse und 22 weiteren Autor:innen. Beteiligte Einrichtung: United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Hospitalization, Vaccination. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, US Centers for Disease Control and Prevention, World Health Organization, Regional Office for Europe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Updated regional data on COVID‐19 epidemiology and vaccination can inform vaccine policies and implementation strategies.

Methods

We used surveillance data on patients hospitalized from the European SARI Vaccine Effectiveness (EuroSAVE) network to describe COVID‐19 epidemiology and COVID‐19 vaccine uptake among adults hospitalized with severe acute respiratory infection (SARI) in six middle‐income countries and areas (CAs) in the WHO European region during 2022–2024. For SARI patients, we collected data on demographics, comorbidities, vaccination status, and hospital course, and a respiratory specimen, which was tested for SARS‐CoV‐2 by RT‐PCR. In October 2024, we surveyed national public health institute staff on national COVID‐19 vaccine guidelines and availability.

Results

Of SARI patients, 833/3982 (20.9%) and 367/3752 (9.8%) tested positive for SARS‐CoV‐2 during May 2022–April 2023 and May 2023–April 2024, respectively. Of COVID‐19 patients, 857 (71.4%) were ≥60 years old and 713 (59.4%) had ≥1 comorbidity. A higher proportion of COVID‐19 patients required mechanical ventilation (30 [8.2%] vs. 23 [2.8%], p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesHospitalizationVaccinationVaccination CoverageHumansMiddle AgedAdultFemaleMaleEuropeSARS-CoV-2AgedYoung AdultAdolescent

Stichwörter der Autor:innen

COVID‐19 epidemiologyCOVID‐19 vaccinesCOVID‐19 virus disease

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Institute of Public Health, Tirana, Albania.
  • Institute of Public Health, Skopje, Republic of North Macedonia.
  • National Institute of Public Health, Belgrade, Serbia.
  • National Center for Disease Control and Public Health, Tbilisi, Georgia, USA.
  • National Institute of Public Health, Pristina, Kosovo.

ORCID-Profile: Erin Rachel Whitehouse, Paul Elish, Besfort Kryeziu, James Humphreys, Mark A Katz

Förderung

  • World Health Organization
  • US Centers for Disease Control and Prevention
  • World Health Organization, Regional Office for Europe

Zitieren

APA

Whitehouse, E. R., Elish, P., Kureta, E., Kochinski, D., Plavsa, D., Chakhunashvili, G., Kryeziu, B., Abdyldaeva, S., Ruiz, M. A. S., Cohuet, S., Humphreys, J., Mersini, K., Artemchuk, O., Stosic, M., Tarkhan-Mouravi, O., Kalaveshi, A., Otorbaeva, D., Stavridis, K., Bino, S., …, & Katz, M. A. (2025). COVID‐19 Hospitalizations, Vaccine Uptake, Vaccination Guidelines, and Vaccine Availability in Six Middle‐Income Countries and Areas in Europe, May 2022–April 2024. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70126

Vancouver

Whitehouse ER, Elish P, Kureta E, Kochinski D, Plavsa D, Chakhunashvili G, et al. COVID‐19 Hospitalizations, Vaccine Uptake, Vaccination Guidelines, and Vaccine Availability in Six Middle‐Income Countries and Areas in Europe, May 2022–April 2024. Influenza and Other Respiratory Viruses. 2025. doi:10.1111/irv.70126

BibTeX
@article{Whitehouse2025,
  author = {Whitehouse, Erin Rachel and Elish, Paul and Kureta, Elona and Kochinski, Dragan and Plavsa, Dragana and Chakhunashvili, Giorgi and Kryeziu, Besfort and Abdyldaeva, Sayragul and Ruiz, Miguel Angel Sanchez and Cohuet, Sandra and Humphreys, James and Mersini, Kujtim and Artemchuk, Oksana and Stosic, Maja and Tarkhan-Mouravi, Olgha and Kalaveshi, Ariana and Otorbaeva, Dinagul and Stavridis, Kristina and Bino, Silvia and Widdowson, Marc-Alain and Leidman, Eva and Finci, Iris and Katz, Mark A},
  title = {COVID‐19 Hospitalizations, Vaccine Uptake, Vaccination Guidelines, and Vaccine Availability in Six Middle‐Income Countries and Areas in Europe, May 2022–April 2024},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2025},
  doi = {10.1111/irv.70126}
}
Kostenlos starten →